S&P Futures
3,824.50 -9.50 (-0.25%) Dow Futures
30,857.00 -79.00 (-0.26%) Nasdaq Futures
11,787.00 -21.50 (-0.18%) Russell 2000 Futures
1,734.30 -7.40 (-0.42%) Crude Oil
99.72 +0.22 (+0.22%) Gold
1,764.10 +0.20 (+0.01%)
Sorrento Therapeutics, Inc. (SRNE)
After hours:
Chart Events
Performance Outlook
| Previous Close | 2.1500 |
| Open | 2.1000 |
| Bid | 0.0000 x 38800 |
| Ask | 0.0000 x 28000 |
| Day's Range | 2.0970 - 2.5700 |
| 52 Week Range | 1.1500 - 9.6300 |
| Volume | |
| Avg. Volume | 10,324,920 |
| Market Cap | 995.702M |
| Beta (5Y Monthly) | 2.43 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.5270 |
| Earnings Date | May 11, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 21.00 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for SRNE
Related Research
- Sorrento Therapeutics, Inc.Technical Assessment: Bearish in the Intermediate-TermMarket sentiment remains in the tank and the stock market simply cannot put together a decent rally. The National Association of Active Investment Managers (NAAIM) exposure index has fallen back to 20%, an extremely low equity exposure and a very bearish stance toward equities. This is the second time the index has dropped to 20% in the past six weeks. The seven-week average of exposure has fallen to 30%, the lowest since the pandemic low, as well as in 2015, 2011, and 2008/2009.RatingFair ValueEconomic Moat6 days agoArgus Research
- GlobeNewswire
Scilex Holding Company, a Sorrento Company, announces that the Honorable Tommy G. Thompson has joined the Scilex Board of Directors
PALO ALTO, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex”), a nearly 100% (or over 99.9%) majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a commercial biopharmaceutical company focused on developing and commercializing non-opioid therapies for patients with acute and chronic pain, announced today the appointment of the Honorable Tommy G. Thompson, former Secretary of the United States Department of Health and Human Services (“HHS”)
- Motley Fool
Why Sorrento Therapeutics Stock Is Jumping Today
Shares of small-cap biotech Sorrento Therapeutics (NASDAQ: SRNE) were up by a noteworthy 13.3% on heavy trading volume as of 11:24 a.m. ET Tuesday. What's particularly interesting about this double-digit percentage move is that the company hasn't announced any significant material events in about a month. The biotech stock shed an eye-catching 56% of its value amid that downturn.
- GlobeNewswire
Sorrento Therapeutics, Inc. announces the appointment of the Honorable Tommy G. Thompson, as Covid-19 Special Consultant to Chairman and CEO Henry Ji
SAN DIEGO, June 24, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a commercial and clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies and diagnostics, announced today the appointment of the Honorable Tommy G. Thompson, former Secretary of the United States Department of Health and Human Services (“HHS”) and former Governor of Wisconsin, as Covid-19 special consultant to Sorrento’s Chairman and CEO Henry Ji. G
